Latest Cancer News

  • Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia 09-26-2016...

    Acccording to results recently published in the New England Journal of Medicine, young adults with CD20-positive, Philadelphia chromosome  (PH)-negative acute lymphoblastic leukemia (ALL), experience survival benefits with the addition of [...]

  • CDC Vaccine Information and Recommendations for the 2016/17 Influenza Season 09-22-2016...

    With the start of a new school year and the approaching winter, it’s time to get informed about the most critical information regarding the 2016/17 influenza vaccines and CDC’s vaccination [...]

  • Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma 09-20-2016...

    The treatment combination consisting of Cotellic® (cobimetinib) plus Zelboraf® (vemurafenib) improves overall survival for patients with advanced, BRAF (V600) mutation-positive melanoma. These confirmatory results have led to this treatment combination [...]

  • FDA Grants Breakthrough Therapy Designation to Keytruda® for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer 09-14-2016...

    The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Keytruda® (pembrolizumab) for first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). The FDA’s Breakthrough [...]